Related Experiment Video
Updated: Jul 11, 2026
09:06
A Low-cost Method for Analyzing Seizure-like Activity and Movement in Drosophila
Published on: February 19, 2014
Lafora disease, seizures and sugars
D M Andrade1, J Turnbull, B A Minassian
1Division of Neurology, Krembil Neuroscience Centre, University of Toronto, Toronto Western Hospital, Toronto, Canada.
Summary
Lafora disease, a severe epilepsy, is fatal in young adults. Recent genetic discoveries offer hope for future treatments, though no cure currently exists.
Area of Science:
- Neuroscience
- Genetics
- Epilepsy Research
Background:
- Lafora disease (LD) is the most severe inherited epilepsy, presenting in adolescence.
- It is characterized by progressive myoclonus epilepsy and is universally fatal by the third decade.
- Currently, no preventative measures or cures are available for Lafora disease.
Purpose of the Study:
- To review the clinical manifestations of Lafora disease.
- To focus on the molecular underpinnings and genetic basis of Lafora disease.
- To highlight recent advancements in understanding Lafora disease for potential therapeutic development.
Main Methods:
- Literature review of clinical and molecular studies on Lafora disease.
- Analysis of genetic findings related to Lafora disease.
- Synthesis of current knowledge on the molecular pathology of Lafora disease.
Main Results:
- Identification of genes responsible for Lafora disease has advanced understanding.
- Molecular insights reveal potential pathways for therapeutic intervention.
- Despite progress, effective treatments remain under development.
Conclusions:
- Lafora disease remains a devastating neurological disorder with no cure.
- Advances in molecular genetics provide a foundation for developing targeted therapies.
- Further research into the molecular aspects of Lafora disease is crucial for future treatment strategies.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:19Seizures ll: Types
Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...